Infectious Disease Connect Expands Telemedicine Services
April 16, 2024 09:15 ET
|
Infectious Disease Connect
PITTSBURGH, April 16, 2024 (GLOBE NEWSWIRE) -- Infectious Disease Connect (ID Connect), a leading infectious diseases telemedicine and software solutions company, has expanded its services to meet...
Sequel’s twiist™ Automated Insulin Delivery System Receives FDA 510(k) Clearance
March 18, 2024 07:05 ET
|
Sequel Med Tech
Sequel’s twiist™ automated insulin delivery system receives FDA 510(k) clearance. Significant advancements for people with people with Type 1 diabetes.
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
March 13, 2024 07:55 ET
|
Catalyst Pharmaceuticals, Inc.
AGAMREE® (vamorolone) a Novel Alternative Corticosteroid with Demonstrated Properties in Maintaining Efficacy and a Well-Tolerated Side Effect Profile Available in the U.S. by Prescription for...
Provectus Biopharmaceuticals Announces Notices of Allowance and Award for U.S. Patents of Rose Bengal Sodium in Virology, Pediatric Solid Tumor Cancers, and Vaccines
March 12, 2024 08:00 ET
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 12, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that the United States Patent and Trademark Office...
Evolving pediatric care needs in community-based settings
January 30, 2024 08:49 ET
|
WellSpan Health
York, Pa., Jan. 30, 2024 (GLOBE NEWSWIRE) -- WellSpan’s longstanding commitment to providing quality children’s health care is at the core of our mission and stretches across all communities we...
Analysis of Global Pediatric Neuroblastoma Treatment Markets, 2018-2033: Unveiling Trends in Emerging Therapies, Personalized Medicine, Access to Treatment, and Patient Advocacy & Support
January 18, 2024 05:33 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Pediatric Neuroblastoma Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global pediatric...
Novel AI platform matches cardiologists in detecting rheumatic heart disease
January 16, 2024 08:00 ET
|
Children's National Hospital
WASHINGTON, D.C., Jan. 16, 2024 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) has the potential to detect rheumatic heart disease (RHD) with the same accuracy as a cardiologist, according to new...
Pediatric Perfusion Market Poised for Growth, Expected to Surpass USD 829 Million by 2030
December 20, 2023 10:28 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Perfusion Market Size, Share & Trends Analysis Report By Product (Pediatric Oxygenators, Pediatric Cannulae, Pediatric Blood Pumps), By...
Pediatric Clinical Trials Market Forecasted Growth with New Innovations and Global Reach in 2023
December 20, 2023 10:08 ET
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Pediatric Clinical Trials Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The pediatric clinical trials...
ARPA-H Awards $3.5 Million Contract to BelleTorus Corp. (Belle.ai) to Expand Pediatric Healthcare Access Using Artificial Intelligence
October 11, 2023 06:12 ET
|
Belle.ai
ARPA-H awards $3.5 million contract to Belle.ai and UHP to develop an AI-driven pediatric telehealth solution for skin, ear, and throat conditions.